The Food and Drug Administration (FDA) warns the public against counterfeit versions of anti-rabies for human use.
The FDA also reminds distributors and retailers to only purchase Rabipur PCEC rabies vaccine from establishments with FDA license.
Based on the inspection of the FDA, Rabipur have two counterfeit versions. This was also verified by its Marketing Authorization Holder, GlaxoSmithKline Philippines Inc.
The box label of the fake version of the vaccine has a paler shade of gray compared to the original. Its font is not in bold format and the QR code is printed in darker ink.
There is also an email address — ‘E-Mail:CS@bd.com’ — printed in the label of the sterile syringe and needle.
For the original version, the box label should be in a darker shade of gray, with a bold format. Its QR code should be printed in lighter ink. The ‘E-Mail:CS@bd.com’ should not be in the label of the sterile syringe and needle.
The FDA also confirmed that Batch no. 3503 and Batch no. 3479 were counterfeited.
The agency also called on the Bureau of Customs (BOC) to block entry of counterfeit Rabipur vaccines at all ports of entry in the country.—AAC
The post FDA warns against counterfeit anti-rabies vaccine for human use appeared first on UNTV News.